Free Trial

Chemed (CHE) Earnings Date, Estimates & Call Transcripts

Chemed logo
$435.82 +0.91 (+0.21%)
Closing price 08/8/2025 03:59 PM Eastern
Extended Trading
$435.21 -0.61 (-0.14%)
As of 08/8/2025 06:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Chemed Earnings Summary

Chemed issued Q2 2025 earnings on July 29, 2025, reporting an EPS of $4.27, which missed analysts' consensus estimates of $6.02 by $1.75. Quarterly revenue rose 3.8% year-over-year to $618.80 million, below analyst estimates of $650.60 million. With a trailing EPS of $19.45 and a P/E Ratio of 22.41, Chemed's earnings are expected to grow 8.73% next year, from $21.43 to $23.30 per share.

Latest Q2
Earnings Date
Jul. 29Estimated
Consensus EPS
(Jul. 29)
$6.02
Actual EPS
(Jul. 29)
$4.27 Missed By -$1.75
Actual Revenue
(Jul. 29)
$618.80M

Q2 2025 Earnings Resources

Get Chemed Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Chemed and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

CHE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CHE Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Chemed Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany EPS Guidance
Q1 20251$5.87$5.87$5.87
Q2 20251$6.14$6.14$6.14

Chemed Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
7/29/2025Q2 2025$6.02$4.27 -$1.75$3.57$650.60M$618.80M
4/23/2025Q1 2025$5.59$5.63+$0.04$4.86$641.78M$646.94M
10/29/2024Q3 2024$5.76$5.64 -$0.12$5.66$612.22M$606.18M
7/24/2024Q2 2024$5.59$5.47 -$0.12$5.37$599.20M$595.88M
4/24/2024Q1 2024$5.09$4.68 -$0.41$5.12$587.18M$589.23M
2/27/2024Q4 2023$6.25$6.60+$0.35$7.30$586.64M$585.90M
10/25/2023Q3 2023$4.92$5.32+$0.40$5.71$558.42M$564.53M

Chemed Earnings - Frequently Asked Questions

Chemed (NYSE:CHE) last announced its quarterly earning data on Tuesday, July 29, 2025. Learn more on CHE's earnings history.

Chemed updated its FY 2025 earnings guidance on Tuesday, July, 29th. The company provided earnings per share (EPS) guidance of 22.000-22.300 for the period, compared to the consensus EPS estimate of 23.330. The company issued revenue guidance of -.

In the previous quarter, Chemed (NYSE:CHE) missed the analysts' consensus estimate of $6.02 by $1.75 with a reported earnings per share (EPS) of $4.27. Learn more on analysts' earnings estimate vs. CHE's actual earnings.

The conference call for Chemed's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Chemed's latest earnings report can be read online.
Read Transcript

Chemed (NYSE:CHE) has a recorded annual revenue of $2.43 billion.

Chemed (NYSE:CHE) has a recorded net income of $302 million. CHE has generated $19.45 earnings per share over the last four quarters.

Chemed (NYSE:CHE) has a trailing price-to-earnings ratio of 22.41 and a forward price-to-earnings ratio of 20.34. The price/earnings-to-growth ratio is 2.4.

Chemed's earnings are expected to grow from $21.43 per share to $23.30 per share in the next year, which is a 8.73% increase.

More Earnings Resources from MarketBeat



This page (NYSE:CHE) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners